Procyte Expands Distribution of Wound Care Line
Distribution Agreement for Far East Established
REDMOND, Wash., Sept. 29 /PRNewswire/ -- ProCyte Corporation (Nasdaq: PRCY - news) today announced the
expansion of its distribution agreement for wound care products with Tanox Biosystems Inc. to include several additional
countries in the Far East.
The initial agreement signed May 5th, 1998 covered the People's Republic of China, Hong Kong and Taiwan for Iamin(R) Gel
and OsmoCyte(R) Pillow Dressings. This agreement has now been broadened to cover Singapore, Thailand, Malaysia,
Philippines and Indonesia where registration activity will begin immediately.
Approval from the Ministry of Health in China has already been received for product shipment, which should begin before the
end of 1998. Additional approvals and product launches are expected throughout 1999.
''The professionalism and expertise that Tanox displayed in quickly gaining approvals to begin marketing gives us great
confidence in their local knowledge and ability to make these products successful'', said Jack Clifford, President & CEO. ''Our
strategy of selecting a significant partner in each geographic segment of the world is working. We continue to maximize
distribution opportunities with key players in the global market.''
This report may contain forward looking statements. The Company's results may vary significantly from quarter to quarter and
will depend among other factors on product launches and market acceptance, manufacturing contracts, and distribution
agreements.
ProCyte Corporation is a healthcare company which develops, manufactures and markets products for tissue repair, skin health
and hair care. The Company's products incorporate its patented copper peptide technology and are marketed both directly and
through distribution partners.
|
